Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 31/01/2010 Microscope image of fully differentiated fat cells.

    A view into the genome provides information on the lipid metabolism

    Since its foundation around 10 years ago the VIVIT institute in Dornbirn and Feldkirch has been dealing with the impact of disorders of the sugar and lipid metabolisms on the pathogenesis of diseases such as atherosclerosis liver damage or coronary heart disease.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-view-into-the-genome-provides-information-on-the-lipid-metabolism
  • Press release - 21/01/2010 European Molecular Biology Laboratory

    Open access drug discovery database launches with half a million compounds

    ChEMBLdb a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets was launched on January 18 2010 with information on over half a million compounds. The data lie at the heart of translating information from the human genome into successful new drugs in the clinic.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/open-access-drug-discovery-database-launches-with-half-a-million-compounds
  • Press release - 21/01/2010 08495_de.jpg

    Resequencing: HybSelect from febit in use

    The Molecular Genetics Core Facility (MGCF) at Children’s Hospital Boston chose febit’s HybSelect technology which will enable genetics researchers to conduct the highly economic targeted enrichment of genes of interest for resequencing. In January the core facility will be receiving the Geniom RT Analyzer® from febit to perform HybSelect.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/resequencing-hybselect-from-febit-in-use
  • Press release - 14/01/2010 Different Arabidopsis plants (Photo: Max Planck Society)

    Evolution caught in the act

    Mutations are the raw material of evolution. Charles Darwin already recognized that evolution depends on heritable differences between individuals: those who are better adapted to the environment have better chances to pass on their genes to the next generation. A species can only evolve if the genome changes through new mutations, with the best new variants surviving the sieve of selection. Scientists at the Max Planck Institute for…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/evolution-caught-in-the-act
  • Dossier - 11/01/2010 Opponents of genetic engineering have repeatedly destroyed fields with genetically modified maize.

    Green genetic engineering – a controversial future technology

    Green genetic engineering comprises a plethora of methods that enable the production of genetically modified (i.e. transgenic) plants by introducing extra genes, which are often foreign to the species into which they are introduced, into a plant genome. The number to be introduced can vary from one single gene to several genes. For example, in order to establish a new and foreign metabolic pathway in a particular plant, several genes need to be…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/green-genetic-engineering-a-controversial-future-technology
  • Press release - 17/12/2009 Portrait of professor doctor Peter Lichter

    Germany Starts Its Part in the International Cancer Genome Project

    German scientists will participate in the largest and most ambitious biomedical research project since the Human Genome Project. Coordinated by the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), the German participants of the International Cancer Genome Consortium (ICGC) will start their work in early January. Their aim is to analyze the molecular causes of childhood brain tumors.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/germany-starts-its-part-in-the-international-cancer-genome-project
  • Press release - 01/12/2009 10262_de.jpg

    Stefan Wiemann elected new spokesman of the German Genome Research Network

    Associate Professor (PD) Dr. Stefan Wiemann of the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) has been elected spokesman of the Project Committee of the National Genome Research Network. This funding programme supports projects in medical genome research aimed at fighting relevant widespread diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/stefan-wiemann-elected-new-spokesman-of-the-german-genome-research-network
  • Press release - 27/11/2009 Hertie Institute

    Gene Mutations Underlying Risk for Parkinson's Disease

    Two genes containing mutations known to cause rare familial forms of parkinsonism are also associated with the more common, sporadic form of the disease where there is no family history, researchers have found. The finding came in the largest genome-wide association study (GWAS) reported to date involving Parkinson's disease.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-mutations-underlying-risk-for-parkinson-s-disease
  • Press release - 23/11/2009 GATC Biotech AG Logo

    GATC Biotech soon opens sequencing laboratory in London

    GATC Biotech Europes leading sequencing service provider for industrial and academic research announces that it will open a sequencing laboratory in London to provide scientists in UK and Ireland with single sample sequencing services. The GATC London Laboratory will be situated in the London BioScience Innovation Centre LBIC and will start operations on January 4 2010.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-soon-opens-sequencing-laboratory-in-london
  • Article - 19/11/2009 Cellzome Logo

    Cellzome - kinase inhibitors for therapy

    Cellzome is a privately-owned biotechnology company which develops new drugs for the treatment of rheumatoid arthritis, multiple sclerosis and chronic inflammatory intestinal diseases at its two company sites in Heidelberg (Germany) and Cambridge (UK).

    https://www.gesundheitsindustrie-bw.de/en/article/news/cellzome-kinase-inhibitors-for-therapy
  • Article - 19/11/2009 Prof. Iwona Adamska and biologist Jens Lohscheider working at a clean bench in the laboratory

    Iwona Adamska helps plants exposed to light stress

    Light is a vital element for plants. They require light to carry out photosynthesis and to produce their body substance from inorganic substances such as water and carbon dioxide. On the other hand plants can also suffer from too much light. Plants have developed a number of protective mechanisms to survive light stress situations. The biologist Prof. Iwona Adamska from the University of Constance is looking closely into these protective…

    https://www.gesundheitsindustrie-bw.de/en/article/news/iwona-adamska-helps-plants-exposed-to-light-stress
  • Press release - 17/11/2009 The photo shows the team from Freiburg at the prize award ceremony at the Massachusetts Institute of Technology (MIT)

    iGEM team Freiburg: a standing order for gold medals

    The Bioware team from Freiburg, an important part of the bioss cluster of excellence, has once again achieved resounding success: one gold medal and two special prizes at the iGEM competition (international Genetically Engineered Machine), the largest event for up-and-coming scientists focusing on synthetic biology. It was the turn of the research group heads, junior professor Dr. Kristian Müller and Dr. Katja Arndt, to participate in the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/igem-team-freiburg-a-standing-order-for-gold-medals
  • Press release - 16/11/2009 10118_de.jpg

    No-Entry Zones for AIDS Virus

    The AIDS virus (HIV) inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-entry-zones-for-aids-virus
  • Article - 16/11/2009 Logo of the ERA-Net vSEED project. The logo shows four differently coloured plant seeds from where computer cables emerge.<br />

    New network for systems biology seed research

    What happens to plant seeds during germination? Researchers led by Dr. Gerhard Leubner from the University of Freiburg in collaboration with six international groups of researchers will be jointly looking into these processes. The virtual Seed (vSEED) consortium took first place in a field of 54 contestants in the European Research Era-Net Plant Genomics competition. What makes the scientists’ project so special is that they are planning to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-network-for-systems-biology-seed-research
  • Press release - 11/11/2009 10061_de.jpg

    Hematopoietic stem cell treatment with a new gene therapy vector: A first success treating a brain disease

    Two children with adrenoleukodystrophy (ALD), a fatal brain disease, have been successfully treated with a new gene therapy vector. Two years after treatment, the disease evolution has been stopped, and no adverse effect of the gene therapy has been observed so far. The results of this clinical trial conducted by Drs Nathalie Cartier and Patrick Aubourg (Inserm, France) in collaboration with European partners have just been published in Science…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hematopoietic-stem-cell-treatment-with-a-new-gene-therapy-vector-a-first-success-treating-a-brain-di
  • Article - 28/10/2009 The photo shows a green wine leaf with many red spots.

    State Viticulture Institute to combat mildew

    Powdery and downy mildew can destroy entire wine harvests. More than 150 years ago, breeders attempted to increase the plants’ natural resistance to mildew by crossing them with more mildew-resistant grape varieties as an alternative to external abatements using fungicides. The majority of breeders soon abandoned the effort; only a handful of breeders, including biologists from the State Viticulture Institute in Freiburg, still believed that this…

    https://www.gesundheitsindustrie-bw.de/en/article/news/state-viticulture-institute-to-combat-mildew
  • Article - 22/10/2009 The schematic shows the evolution of diatoms through primary endosymbiosis. A host cell has taken up a cyanobacterium and transformed into an organelle.<br />

    On the track of fascinating diatoms

    Diatoms make a considerable contribution to the production of oxygen and biomass in the worlds oceans and aquatic ecosystems. However up until now little is known about the molecular biology and chemistry of these eukaryotic algae. Prof. Peter Kroth and his team at the University of Constance are hoping to shed more light on these algae. The team has recently been involved in the deciphering of the Phaeodactylum tricornutum genome research that…

    https://www.gesundheitsindustrie-bw.de/en/article/news/on-the-track-of-fascinating-diatoms
  • Press release - 13/10/2009

    Polyclone partners with Innovendia Consulting in Germany and Europe

    European biotech-platform and drug discovery companies will have easier access to Polyclone Bioservices assay design and validation services through its newly announced partnership with Innovendia Consulting from Owingen. EU and national government funded consortia will benefit from the more immediate availability of Polyclones unique combination of in vitro in silico assay design and validation capabilities.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/polyclone-partners-with-innovendia-consulting-in-germany-and-europe
  • Press release - 24/09/2009 09679_de.jpg

    CeGAT: Tracking genes using cutting-edge technologies

    To adequately meet the growing demand for genetic diagnostics doctor scientist and bioinformatician Dr. Saskia Biskup and her husband business graduate Dr. Dirk Biskup founded the Center for Genomics and Transcriptomics or CeGAT for short in July 2009. As a supplier of DNA and RNA sequencing in the STERN BioRegion CeGAT which is based in the Technology park Tübingen Reutlingen TTR uses state-of-the-art high-throughput technologies to examine…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-tracking-genes-using-cutting-edge-technologies
  • Article - 10/09/2009 Trigger factor (red) in a complex formed with the ribosome (grey): Trigger factor binds to the ribosomal protein L23 (green) and bends over the ribosomal tunnel exit and hence over the nascent protein (yellow).

    Chaperone research using baker’s yeast and bacteria

    Protein misfolding and aggregation can lead to neurodegenerative diseases such as Alzheimers. Prof. Elke Deuerling at the University of Constance is investigating the molecular helpers the chaperones and the key role that they have in protein folding. Deuerling uses the bakers yeast Saccharomyces cerevisiae and the bacterium Eschericia coli for her studies. Her studies involving E. coli have now shown that ribosome-associated chaperones are…

    https://www.gesundheitsindustrie-bw.de/en/article/news/chaperone-research-using-baker-s-yeast-and-bacteria
  • Press release - 10/09/2009

    Genome-wide study to identify risk factors of Alzheimer’s disease

    A study carried out by an international team of scientists, including scientists from the Freiburg University Medical Centre, pooled 16,000 probands and produced large datasets for the identification of genes with an elevated risk for Alzheimer’s disease.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genome-wide-study-to-identify-risk-factors-of-alzheimer-s-disease
  • Article - 10/09/2009 Portrait of professor doctor Karl Lenhard Rudolph

    Excessive numbers of ageing stem cells accumulate without a guardian

    Adult stem cells grow older too. A group of researchers focusing on the ageing of stem cells at the Max Planck Institute in Ulm under the leadership of Leibniz prizewinner Lenhard Rudolph, has now made a surprising discovery in their research into telomer-associated ageing, which further substantiates this hypothesis.

    https://www.gesundheitsindustrie-bw.de/en/article/news/excessive-numbers-of-ageing-stem-cells-accumulate-without-a-guardian
  • Article - 26/08/2009 The photo shows a small fly with red eyes.

    Are fruit flies on the rise again?

    An inconspicuous buzzing insect – it is difficult to imagine that such a creature could be used as a model for humans. Nevertheless, since the beginning of the 20th century Drosophila melanogaster has provided us with decisive insights into human genetics, development and neurobiology. Prof. Dr. Karl-Friedrich Fischbach of the University of Freiburg has been focusing on the development and function of the fruit fly brain for several decades. What…

    https://www.gesundheitsindustrie-bw.de/en/article/news/are-fruit-flies-on-the-rise-again
  • Dossier - 26/08/2009 20433_de.jpg

    Model organisms

    Given that everything is very individual in nature, how can a biologist come up with general statements about how life functions? The answers can only be found using models that represent the entire whole. Modern research uses representative species from the kingdom of bacteria, fungi, plants and animals to glean information about fundamental biological principles. How can the knowledge gained be transferred to other organisms, including humans?…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/model-organisms
  • Press release - 10/08/2009

    How do immune cells recognise infectious pathogens?

    Scientists of the University of Heidelberg and the German Cancer Research Centre have clarified the functional principles of an important receptor for bacterial infections: immune cells recognise bacterial and viral pathogens with a receptor known as toll-like receptor 9 (TLR9), which mediates biochemical reaction chains in order to fend off intruders. This discovery made by the Heidelberg researchers paves the way to develop new anti-infective…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-do-immune-cells-recognise-infectious-pathogens

Page 11 / 14

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search